ID

34601

Descrizione

The I-KAN Study: Internet Insulin Education for Kansans; ODM derived from: https://clinicaltrials.gov/show/NCT01408628

collegamento

https://clinicaltrials.gov/show/NCT01408628

Keywords

  1. 19/01/19 19/01/19 -
  2. 17/04/20 17/04/20 -
  3. 18/04/20 18/04/20 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

19 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Type 2 Diabetes NCT01408628

Eligibility Type 2 Diabetes NCT01408628

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
t2dm, meets provider criteria for insulin initiation; starting or having started insulin treatment no longer than six months prior to enrollment or has not yet committed to starting insulin but has agreed to participate in the education
Descrizione

ID.1

Tipo di dati

boolean

broadband internet and experience with logging into a password-protected site (e.g., ecommerce or social networking);
Descrizione

ID.2

Tipo di dati

boolean

ability to purchase or otherwise acquire glargine/detemir insulin and testing supplies.
Descrizione

ID.3

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of oral glucocorticoids or second generation anti-psychotics;
Descrizione

ID.4

Tipo di dati

boolean

previous use of self-administered insulin more than six months prior to enrollment;
Descrizione

ID.5

Tipo di dati

boolean

gestational diabetes or other endocrine conditions causing hyperglycemia; treatment for a malignant condition other than basal cell carcinoma in situ within prior two years;
Descrizione

ID.6

Tipo di dati

boolean

renal insufficiency (ast/alt >2 or concurrent liver disease except nash);
Descrizione

ID.7

Tipo di dati

boolean

pregnant or planning to become pregnant within 6 months;
Descrizione

ID.8

Tipo di dati

boolean

hba1c < 7.0% or ongoing weight loss or persistent fasting hyperglycemia > 250 mg/dl.
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Type 2 Diabetes NCT01408628

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
t2dm, meets provider criteria for insulin initiation; starting or having started insulin treatment no longer than six months prior to enrollment or has not yet committed to starting insulin but has agreed to participate in the education
boolean
ID.2
Item
broadband internet and experience with logging into a password-protected site (e.g., ecommerce or social networking);
boolean
ID.3
Item
ability to purchase or otherwise acquire glargine/detemir insulin and testing supplies.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
use of oral glucocorticoids or second generation anti-psychotics;
boolean
ID.5
Item
previous use of self-administered insulin more than six months prior to enrollment;
boolean
ID.6
Item
gestational diabetes or other endocrine conditions causing hyperglycemia; treatment for a malignant condition other than basal cell carcinoma in situ within prior two years;
boolean
ID.7
Item
renal insufficiency (ast/alt >2 or concurrent liver disease except nash);
boolean
ID.8
Item
pregnant or planning to become pregnant within 6 months;
boolean
ID.9
Item
hba1c < 7.0% or ongoing weight loss or persistent fasting hyperglycemia > 250 mg/dl.
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial